Decipherment and Consideration of 2017th Edition of National Health Insurance Directory
10.3870/j.issn.1004-0781.2018.01.002
- VernacularTitle:2017年版《国家医保药品目录》解读
- Author:
Jinyu LIU
1
;
Dongyan LI
;
Guangjie YANG
;
Ruihua MAO
;
Yufeng DING
Author Information
1. 华中科技大学同济医学院附属同济医院药学部
- Keywords:
Health Insurance Directory;
Adjustment mechanism;
Rational administration of drug
- From:
Herald of Medicine
2018;37(1):6-12
- CountryChina
- Language:Chinese
-
Abstract:
Objective To provide reference for the adjustment of provincial health insurance directory by comparing the differences between 2017 and 2009 edition of National Health Insurance Directory(NHID) and exploring the characteristics of NHID adjustment. Methods The Excel 2016 was used to carry out a comparative analysis of the drugs included in the two editions of NHID from the 4 aspects such as classification,drug name,dosage form and payment range. Results The adjustments of NHID in 2017 include drug variety,payment range,drug classification and coding.A total of 339 drugs were added, of which 133 were chemical drugs with a growth rate of 11.4%,and 206 were Traditional Chinese Medicine with a growth rate of 20.0%.In addition,dosage form was added in 149 drug varieties.The adjustment mainly focuses on chronic diseases such as hypertension and diabetes,serious diseases such as cancer,innovative drugs,and pediatric drugs. Conclusion The adjustment of 2017 edition of NHID embodied the policy thinking of "filling,selecting,supporting innovation and encouraging competition". Moreover,the drug classification,name and coding are more scientific and reasonable.
